Brachytherapy improves outcomes in young men (≤60 years) with prostate cancer: A SEER analysis.

ABSTRACT:

Purpose

The aim of the study was to compare prostate cancer-specific mortality (PCSM) in young men with clinically localized prostate cancer treated by either external beam radiation (EBRT) alone or brachytherapy with or without external beam radiation.

Methods and materials

Utilizing the Surveillance, Epidemiology and End Results database, 15,505 patients ≤60 years of age diagnosed with prostate cancer between 2004 and 2009 and treated with radiation therapy alone were identified. Incidence of PCSM was determined for both groups and compared using competing risk models.

Results

The overall 8-year PCSM for the study population was 1.9% (95% confidence interval [CI]: 1.6-2.2). For patients treated with EBRT or brachytherapy with or without external beam, the 8-year PCS

SUBMITTER: Ashamalla H 

PROVIDER: S-EPMC5568111 | biostudies-literature | 2017 Mar - Apr

REPOSITORIES: biostudies-literature